To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SPPL3TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
412 supporting clones for gene SPPL3 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CB988851 Human Placenta, placenta SPPL3.a 1 to 532 24 to 555   tiling clone,   532/918
(57 %)
6 diff
(99.4 %id)
CB990675 Human Placenta, placenta SPPL3.a 1 to 532 24 to 559       536/830
(64 %)
12 diff
(98.6 %id)
BM853286 myeloma SPPL3.a 14 to 461 1 to 448   tiling clone,   448/448
(100 %)
4 diff
(99.2 %id)
BM559072 eye, retinoblastoma SPPL3.a 16 to 894 21 to 908       888/1059
(83 %)
22 diff
(98.0 %id)
DN999717   SPPL3.a 20 to 532 1 to 513       513/635
(80 %)
6 diff
(99.1 %id)
BU932077 ovary, teratocarcinoma, cell line SPPL3.a 24 to 818 1 to 795       795/927
(85 %)
16 diff
(98.3 %id)
CV573482 cornea, eye SPPL3.a 27 to 608 1 to 582       582/582
(100 %)
5 diff
(99.2 %id)
AK223590 Kidney SPPL3.a 28 to 1699 1 to 1672       1672/1672
(100 %)
2 diff
(99.9 %id)
NM_139015.3   SPPL3.a 28 to 3429 1 to 3402   RefSeq, AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 3402/3402
(100 %)
1 diff
(100.0 %id)
CA390083 eye, RPE/choroid SPPL3.a 31 to 581 1 to 556       556/556
(100 %)
8 diff
(98.6 %id)
BQ686887 ductal carcinoma, cell line, Pancreas SPPL3.a 40 to 533 1 to 494       494/1019
(48 %)
12 diff
(98.9 %id)
BU845461 ovary, teratocarcinoma, cell line SPPL3.a 73 to 985 1 to 925       925/938
(98 %)
29 diff
(97.0 %id)
BQ439988 melanotic melanoma, skin SPPL3.a 89 to 901 1 to 821       821/899
(91 %)
17 diff
(98.2 %id)
BU184212 eye, retinoblastoma SPPL3.a 89 to 532 1 to 444       444/984
(45 %)
5 diff
(99.5 %id)
AL550052 placenta, Placenta Cot 25-normalized SPPL3.a 96 to 1009 1 to 911       911/911
(100 %)
7 diff
(99.3 %id)
AL515380 neuroblastoma, placenta SPPL3.a 110 to 1175 1 to 1063     Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 1063/1063
(100 %)
12 diff
(98.9 %id)
AL514200 neuroblastoma, placenta SPPL3.a 153 to 1216 1 to 1054   fully sequenced,   1054/1054
(100 %)
22 diff
(98.0 %id)
BI546904 brain, hippocampus SPPL3.a 200 to 1098 1 to 901       901/904
(99 %)
37 diff
(96.0 %id)
AK291161   SPPL3.a 202 to 1933 1 to 1732       1732/1732
(100 %)
5 diff
(99.8 %id)
TI_44167583   SPPL3.a 205 to 1098 127 to 1022       896/1025
(87 %)
35 diff
(96.6 %id)
BF966096 brain, hippocampus SPPL3.a 206 to 940 8 to 738       731/794
(92 %)
18 diff
(97.8 %id)
BM553956 brain, medulla SPPL3.a 218 to 1234 1 to 1035       1032/1057
(97 %)
47 diff
(95.6 %id)
BC073910 Testis, embryonal carcinoma SPPL3.a 243 to 2389 1 to 2147   available from MGC, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 2147/2147
(100 %)
1 diff
(100.0 %id)
AY169313 blood SPPL3.a 250 to 1669 1 to 1420       1420/1420
(100 %)
4 diff
(99.8 %id)
AL529147 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized SPPL3.a 303 to 1147 1 to 843       843/843
(100 %)
4 diff
(99.6 %id)
BF527200 anaplastic oligodendroglioma with 1p/19qloss, brain SPPL3.a 374 to 1117 1 to 747       747/883
(84 %)
28 diff
(96.9 %id)
TI_927047639   SPPL3.a 422 to 1583 60 to 1212     Submitted on the opposite strand 1153/1284
(89 %)
22 diff
(98.3 %id)
TI_927047640   SPPL3.a 422 to 1595 59 to 1217     Submitted on the opposite strand 1159/1263
(91 %)
23 diff
(98.2 %id)
TI_927047756   SPPL3.a 422 to 1458 27 to 1063     Submitted on the opposite strand 1037/1198
(86 %)
56 diff
(95.4 %id)
BC101625 Liver, PCR rescued clones SPPL3.a 429 to 1691 1 to 1263       1263/1263
(100 %)
0 diff
(100 %id)
BC101627 Liver, PCR rescued clones SPPL3.a 429 to 1692 1 to 1264       1264/1264
(100 %)
1 diff
(100.0 %id)
AB252457 fetal brain SPPL3.a 432 to 1754 1 to 1323       1323/1323
(100 %)
0 diff
(100 %id)
AJ345030   SPPL3.a 456 to 3429 1 to 2973   tiling clone, AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 2973/2973
(100 %)
2 diff
(100.0 %id)
AJ420898   SPPL3.a 488 to 1668 1 to 1184       1184/1184
(100 %)
14 diff
(98.9 %id)
BG261268 bladder, transitional cell papilloma, cell line SPPL3.a 524 to 1120 64 to 659       596/660
(90 %)
11 diff
(98.4 %id)
CN406292 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 SPPL3.a 540 to 1156 1 to 617       617/617
(100 %)
0 diff
(100 %id)
AK074916   SPPL3.a 541 to 2839 1 to 2300   available from FLJ,   2300/2300
(100 %)
2 diff
(100.0 %id)
DA735378   SPPL3.a 542 to 1376 2 to 829   capped   830/834
(99 %)
20 diff
(97.7 %id)
TI_927045596   SPPL3.a 553 to 1592 20 to 1057       1038/1244
(83 %)
8 diff
(99.4 %id)
TI_927045599   SPPL3.a 553 to 1622 18 to 1082       1065/1231
(86 %)
13 diff
(99.0 %id)
CB160091 Liver SPPL3.a 573 to 1045 1 to 473       473/473
(100 %)
0 diff
(100 %id)
BM542929 embryonal carcinoma, cell line, testis SPPL3.a 581 to 1440 1 to 869       869/1006
(86 %)
13 diff
(98.8 %id)
TI_927047752   SPPL3.a 607 to 1696 1130 to 50     Submitted on the opposite strand 1081/1269
(85 %)
16 diff
(98.8 %id)
BG198307   SPPL3.a 612 to 1120 12 to 522       511/795
(64 %)
23 diff
(97.2 %id)
CK004210 brain/CNS, Human Brain - Cerebellar Cortex SPPL3.a 618 to 1254 1 to 632       632/636
(99 %)
12 diff
(98.2 %id)
TI_927047747   SPPL3.a 632 to 1696 1105 to 45     Submitted on the opposite strand 1061/1254
(84 %)
13 diff
(99.0 %id)
BG290931 bladder, transitional cell papilloma, cell line SPPL3.a 639 to 1429 1 to 787       789/935
(84 %)
35 diff
(96.3 %id)
AW958252   SPPL3.a 647 to 1216 1 to 567       567/567
(100 %)
10 diff
(98.3 %id)
BP238428 Liver SPPL3.a 649 to 1263 1 to 615       615/615
(100 %)
5 diff
(99.2 %id)
BQ954155 leiomyosarcoma, uterus SPPL3.a 653 to 1481 1 to 845       845/876
(96 %)
17 diff
(98.1 %id)
CD245537 White Matter SPPL3.a 661 to 1429 1 to 777       777/886
(87 %)
12 diff
(98.7 %id)
CF265075 Brain glioblastoma SPPL3.a 678 to 1549 1 to 881       879/885
(99 %)
16 diff
(98.2 %id)
AA179201   SPPL3.a 690 to 1120 20 to 451       432/458
(94 %)
3 diff
(99.4 %id)
DA271991 caudate nucleus SPPL3.a 696 to 1316 2 to 623   capped   622/622
(100 %)
1 diff
(99.9 %id)
TI_927047544   SPPL3.a 699 to 1696 1045 to 53     Submitted on the opposite strand 993/1237
(80 %)
9 diff
(99.3 %id)
TI_927047545   SPPL3.a 699 to 1696 1048 to 53     Submitted on the opposite strand 996/1219
(81 %)
2 diff
(99.9 %id)
TI_927047753   SPPL3.a 704 to 1696 1017 to 35     Submitted on the opposite strand 983/1219
(80 %)
16 diff
(98.7 %id)
BP267727 thyroid SPPL3.a 709 to 1286 1 to 578       578/578
(100 %)
3 diff
(99.5 %id)
BP267729 thyroid SPPL3.a 709 to 1275 1 to 567       567/567
(100 %)
3 diff
(99.5 %id)
BP268158 thyroid SPPL3.a 710 to 1290 1 to 581       581/581
(100 %)
3 diff
(99.5 %id)
BF377563 testis_normal SPPL3.a 727 to 1049 324 to 2       323/324
(99 %)
2 diff
(99.4 %id)
BQ321905 colon SPPL3.a 729 to 1082 367 to 15       353/369
(95 %)
1 diff
(99.8 %id)
TI_57166138   SPPL3.a 739 to 1529 55 to 842       788/842
(93 %)
8 diff
(99.1 %id)
DA033101   SPPL3.a 742 to 1301 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
BC025781 Pancreas, Spleen, adult pooled SPPL3.a 749 to 2384 1 to 1637   available from MGC, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 1637/1637
(100 %)
3 diff
(99.9 %id)
BI835474 pooled pancreas and spleen SPPL3.a 750 to 1529 1 to 777   available from MGC,   777/777
(100 %)
3 diff
(99.7 %id)
BP303544   SPPL3.a 763 to 1343 1 to 581       581/581
(100 %)
0 diff
(100 %id)
DA181789 amygdala SPPL3.a 774 to 1327 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA385666 thalamus SPPL3.a 780 to 1275 2 to 497   capped   496/496
(100 %)
0 diff
(100 %id)
BG254307 adenocarcinoma, cell line, Prostate SPPL3.a 789 to 1482 1 to 697       697/999
(69 %)
29 diff
(97.1 %id)
TI_927045597   SPPL3.a 793 to 1696 1 to 903       903/1210
(74 %)
8 diff
(99.4 %id)
BU169396 eye, retinoblastoma SPPL3.a 797 to 1663 1 to 873       873/873
(100 %)
7 diff
(99.2 %id)
N36611 melanocyte SPPL3.a 802 to 1231 1 to 428     Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 428/428
(100 %)
4 diff
(99.1 %id)
TI_927045600   SPPL3.a 804 to 1696 1 to 892       892/1236
(72 %)
6 diff
(99.6 %id)
R12724 whole brain SPPL3.a 816 to 1198 1 to 392       392/474
(82 %)
11 diff
(97.7 %id)
DB446469 testis SPPL3.a 817 to 1256 10 to 450       443/450
(98 %)
15 diff
(96.7 %id)
BM460066 leiomyosarcoma, uterus SPPL3.a 817 to 1785 1 to 979       979/1049
(93 %)
21 diff
(98.0 %id)
BG283134 adenocarcinoma, cell line, Prostate SPPL3.a 822 to 1482 1 to 710       595/1206
(49 %)
32 diff
(97.4 %id)
BX353221 Neuroblastoma Cot 25-normalized SPPL3.a 823 to 1852 1 to 1021       1021/1052
(97 %)
18 diff
(98.3 %id)
CN406296 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells SPPL3.a 829 to 1119 25 to 315       291/315
(92 %)
7 diff
(97.8 %id)
DB209896 trachea SPPL3.a 836 to 1394 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
DA713221   SPPL3.a 843 to 1397 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA757441   SPPL3.a 843 to 1394 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
BM845199 myeloma SPPL3.a 848 to 1408 1 to 561       561/561
(100 %)
0 diff
(100 %id)
R64681 placenta SPPL3.a 849 to 1234 1 to 391       391/401
(97 %)
10 diff
(97.6 %id)
BM564217 brain, medulla SPPL3.a 855 to 1743 15 to 904       890/1088
(81 %)
20 diff
(98.2 %id)
DA344267 substantia nigra SPPL3.a 860 to 1437 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
DA354684 substantia nigra SPPL3.a 860 to 1411 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
R31994 placenta SPPL3.a 860 to 1210 1 to 364       361/366
(98 %)
24 diff
(93.5 %id)
DA267404 caudate nucleus SPPL3.a 869 to 1429 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA933345 Spleen SPPL3.a 874 to 1445 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
BG104666 adrenal cortex carcinoma, cell line, adrenal gland SPPL3.a 875 to 1482 1 to 609       609/898
(67 %)
8 diff
(99.2 %id)
DA814018   SPPL3.a 889 to 1338 2 to 451   capped   450/450
(100 %)
0 diff
(100 %id)
DA697650   SPPL3.a 908 to 1478 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
BM564838 eye, retinoblastoma SPPL3.a 910 to 1597 1 to 691       691/1128
(61 %)
10 diff
(99.2 %id)
BG697065 skin SPPL3.a 937 to 1670 1 to 734       734/734
(100 %)
0 diff
(100 %id)
R51410 whole brain SPPL3.a 946 to 1410 1 to 477     Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 477/488
(97 %)
23 diff
(95.3 %id)
BM852787 Ascites, stomach SPPL3.a 954 to 1523 1 to 570       570/570
(100 %)
1 diff
(99.9 %id)
TI_927045601   SPPL3.a 959 to 1696 1 to 737       737/1239
(59 %)
7 diff
(99.5 %id)
TI_927045598   SPPL3.a 960 to 1696 1 to 736       736/1256
(58 %)
5 diff
(99.7 %id)
CX165967 human embryonic stem cells differentiated toan early endodermal cell type SPPL3.a 960 to 1698 1 to 739       739/739
(100 %)
0 diff
(100 %id)
BP221374 colon SPPL3.a 961 to 1521 1 to 561       561/561
(100 %)
3 diff
(99.5 %id)
BP377282 uterus SPPL3.a 961 to 1523 1 to 563       563/570
(98 %)
1 diff
(99.9 %id)
BF529773 anaplastic oligodendroglioma with 1p/19qloss, brain SPPL3.a 962 to 1669 1 to 697       697/697
(100 %)
21 diff
(97.0 %id)
BF184232 bone marrow, from chronic myelogenous leukemia SPPL3.a 996 to 1737 1 to 727       727/778
(93 %)
27 diff
(96.6 %id)
DA253093 caudate nucleus SPPL3.a 1020 to 1576 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
AA332170 Embryo, 8 weeks SPPL3.a 1025 to 1338 1 to 314       314/314
(100 %)
0 diff
(100 %id)
AW965314   SPPL3.a 1026 to 1617 1 to 593       591/594
(99 %)
6 diff
(99.0 %id)
DA536890 heart SPPL3.a 1043 to 1623 2 to 582   capped   581/586
(99 %)
1 diff
(99.9 %id)
BQ931016 sciatic nerve SPPL3.a 1070 to 1846 1 to 785       785/975
(80 %)
16 diff
(98.4 %id)
BG995373 head_neck SPPL3.a 1086 to 1301 2 to 217       216/217
(99 %)
13 diff
(94.1 %id)
BG114729 duodenal adenocarcinoma, cell line, small intestine SPPL3.a 1098 to 1793 1 to 691       691/894
(77 %)
14 diff
(98.5 %id)
BQ894132 sympathetic trunk SPPL3.a 1098 to 1935 1 to 845       845/850
(99 %)
20 diff
(97.7 %id)
BM744530 stomach SPPL3.a 1104 to 1674 1 to 571       571/571
(100 %)
0 diff
(100 %id)
AA037159 senescent fibroblast SPPL3.a 1118 to 1586 1 to 469       469/469
(100 %)
0 diff
(100 %id)
R41078   SPPL3.a 1122 to 1503 363 to 1       363/374
(97 %)
31 diff
(91.8 %id)
H48364 liver and spleen SPPL3.a 1139 to 1577 1 to 442       442/443
(99 %)
14 diff
(96.9 %id)
H60238 liver and spleen SPPL3.a 1139 to 1482 1 to 349       349/403
(86 %)
6 diff
(98.6 %id)
CD512290 Pooled-Skin SPPL3.a 1139 to 1597 1 to 462       462/648
(71 %)
9 diff
(98.7 %id)
R20363 whole brain SPPL3.a 1156 to 1479 1 to 329     Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 329/387
(85 %)
8 diff
(98.0 %id)
H06563 whole brain SPPL3.a 1156 to 1552 1 to 405     Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 405/456
(88 %)
15 diff
(96.8 %id)
AL514199 neuroblastoma, placenta SPPL3.a 1200 to 2199 986 to 1   fully sequenced,   986/986
(100 %)
18 diff
(98.2 %id)
AL529146 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized SPPL3.a 1272 to 1918 918 to 273       646/649
(99 %)
4 diff
(99.4 %id)
AL574017 placenta, Placenta Cot 25-normalized SPPL3.a 1295 to 2362 1058 to 1       1058/1067
(99 %)
26 diff
(97.6 %id)
BG995376 head_neck SPPL3.a 1316 to 1419 1 to 104       104/104
(100 %)
0 diff
(100 %id)
AL573789 placenta, Placenta Cot 25-normalized SPPL3.a 1316 to 2156 860 to 11       850/872
(97 %)
36 diff
(95.9 %id)
CN406291 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 SPPL3.a 1346 to 1859 1 to 514       514/514
(100 %)
1 diff
(99.9 %id)
BX434558 brain, fetal brain SPPL3.a 1347 to 2213 875 to 6       870/875
(99 %)
13 diff
(98.6 %id)
BI910456 leukocyte SPPL3.a 1366 to 2199 1 to 839       839/839
(100 %)
17 diff
(98.0 %id)
TI_57235762   SPPL3.a 1366 to 2199 32 to 870       839/870
(96 %)
23 diff
(97.4 %id)
CX758482 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass SPPL3.a 1374 to 2153 39 to 814     Submitted on the opposite strand 776/814
(95 %)
10 diff
(98.8 %id)
CN406295 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 SPPL3.a 1388 to 2065 1 to 679       679/679
(100 %)
7 diff
(99.0 %id)
AL536493 brain, fetal brain SPPL3.a 1388 to 2259 1 to 872       872/872
(100 %)
4 diff
(99.6 %id)
CR620843 Placenta Cot 25-normalized SPPL3.a 1389 to 2203 1 to 815       815/815
(100 %)
0 diff
(100 %id)
CR626296 fetal brain SPPL3.a 1389 to 2358 1 to 970       970/970
(100 %)
0 diff
(100 %id)
AL553949 placenta, Placenta Cot 25-normalized SPPL3.a 1389 to 2203 1 to 815   fully sequenced,   815/815
(100 %)
3 diff
(99.7 %id)
H10567 whole brain SPPL3.a 1397 to 1828 1 to 434       434/434
(100 %)
4 diff
(99.1 %id)
AA164612   SPPL3.a 1403 to 1770 1 to 370   fully sequenced,   370/370
(100 %)
6 diff
(98.4 %id)
AA360706   SPPL3.a 1406 to 1723 1 to 319       319/321
(99 %)
4 diff
(98.8 %id)
BG910807 anaplastic oligodendroglioma with 1p/19qloss, brain SPPL3.a 1406 to 2000 24 to 622       599/715
(83 %)
19 diff
(97.4 %id)
AW959008   SPPL3.a 1407 to 1977 1 to 576       576/578
(99 %)
17 diff
(97.1 %id)
AA437178   SPPL3.a 1409 to 1848 14 to 451     Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 438/451
(97 %)
8 diff
(98.3 %id)
CX762901 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass SPPL3.a 1431 to 2151 1 to 721     Submitted on the opposite strand 721/721
(100 %)
1 diff
(99.9 %id)
BE736594 adenocarcinoma, Pancreas SPPL3.a 1442 to 2141 1 to 706       706/834
(84 %)
27 diff
(96.8 %id)
BE164717 head_neck SPPL3.a 1446 to 1827 402 to 20     Submitted on the opposite strand 383/403
(95 %)
1 diff
(99.8 %id)
FN112821 breast carcinoma SPPL3.a 1498 to 1592 94 to 2     Submitted on the opposite strand 93/104
(89 %)
0 diff
(100 %id)
N94194 liver and spleen SPPL3.a 1509 to 1920 1 to 416   fully sequenced,   416/416
(100 %)
14 diff
(96.7 %id)
W87353 liver and spleen SPPL3.a 1509 to 1860 1 to 363   fully sequenced,   363/363
(100 %)
1 diff
(99.8 %id)
BE090735 breast SPPL3.a 1510 to 1860 351 to 1     Submitted on the opposite strand 351/352
(99 %)
4 diff
(98.9 %id)
BF966979 brain, hippocampus SPPL3.a 1519 to 2141 628 to 4       625/628
(99 %)
0 diff
(100 %id)
AL553948 placenta, Placenta Cot 25-normalized SPPL3.a 1522 to 2187 665 to 1   fully sequenced,   665/665
(100 %)
5 diff
(99.3 %id)
BF963256 nervous_normal SPPL3.a 1526 to 1709 184 to 1       184/184
(100 %)
1 diff
(99.5 %id)
AA179191   SPPL3.a 1537 to 2028 493 to 1       493/494
(99 %)
5 diff
(99.0 %id)
DA511719 brain SPPL3.a 1545 to 1901 2 to 357   capped   356/356
(100 %)
2 diff
(99.5 %id)
CN479591 Chondrosarcoma, Left Pubic Bone SPPL3.a 1557 to 2197 659 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 641/641
(100 %)
2 diff
(99.7 %id)
CN406293 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 SPPL3.a 1563 to 2012 1 to 451       451/451
(100 %)
7 diff
(98.5 %id)
BM727737 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid SPPL3.a 1571 to 1883 1 to 313   fully sequenced, Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 313/313
(100 %)
1 diff
(99.7 %id)
BU179226 melanotic melanoma, cell line, skin SPPL3.a 1585 to 2321 30 to 778       749/882
(84 %)
27 diff
(97.0 %id)
BF967759 brain, hypothalamus SPPL3.a 1592 to 2348 815 to 43       773/1079
(71 %)
0 diff
(100 %id)
TI_154109432   SPPL3.a 1592 to 2389 868 to 84   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 785/940
(83 %)
16 diff
(98.3 %id)
CR737023   SPPL3.a 1602 to 2195 610 to 16   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 595/595
(100 %)
3 diff
(99.5 %id)
BF316407 brain, neuroblastoma SPPL3.a 1602 to 2332 1 to 724       724/896
(80 %)
18 diff
(98.0 %id)
AW973905   SPPL3.a 1605 to 2201 596 to 1     Submitted on the opposite strand 596/601
(99 %)
9 diff
(98.6 %id)
CU453532 epidermis SPPL3.a 1622 to 2199 584 to 8     Submitted on the opposite strand 577/587
(98 %)
0 diff
(100 %id)
AW005623 anaplastic oligodendroglioma, brain SPPL3.a 1628 to 2198 571 to 1       571/571
(100 %)
2 diff
(99.7 %id)
AW516590 cervix, tumor SPPL3.a 1654 to 2203 551 to 2       550/551
(99 %)
0 diff
(100 %id)
BQ008170 Chondrosarcoma, Left Pubic Bone SPPL3.a 1658 to 2386 744 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 726/726
(100 %)
10 diff
(98.7 %id)
TI_158433149   SPPL3.a 1661 to 2202 655 to 114   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 542/822
(65 %)
2 diff
(99.8 %id)
BQ012506 placenta SPPL3.a 1661 to 2202 560 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 542/550
(98 %)
6 diff
(99.0 %id)
AL157671 brain SPPL3.a 1665 to 2389 1 to 725   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 725/725
(100 %)
3 diff
(99.6 %id)
CA447893 Chondrosarcoma, Left Pelvis SPPL3.a 1666 to 2389 738 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 720/724
(99 %)
12 diff
(98.4 %id)
AW014546   SPPL3.a 1671 to 2197 544 to 18   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 527/527
(100 %)
1 diff
(99.9 %id)
CR595697 B cells (Ramos cell line) Cot 25-normalized SPPL3.a 1680 to 2802 1 to 1123       1123/1123
(100 %)
0 diff
(100 %id)
AL560826 B cells from Burkitt lymphoma SPPL3.a 1680 to 2659 1 to 981       981/986
(99 %)
6 diff
(99.4 %id)
BM697278 eye, fetal eyes SPPL3.a 1721 to 2357 1 to 633       633/633
(100 %)
10 diff
(98.5 %id)
R64682 placenta SPPL3.a 1733 to 2209 495 to 1       495/501
(98 %)
16 diff
(96.9 %id)
BF353343 head_neck SPPL3.a 1734 to 2046 29 to 340       312/340
(91 %)
6 diff
(98.3 %id)
AI686912 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus SPPL3.a 1736 to 2202 486 to 20   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 467/467
(100 %)
7 diff
(98.6 %id)
AA164613   SPPL3.a 1740 to 2200 461 to 1   fully sequenced,   461/461
(100 %)
3 diff
(99.4 %id)
CD516595 White Matter SPPL3.a 1750 to 2531 19 to 804       786/872
(90 %)
7 diff
(99.2 %id)
BX119417 whole brain SPPL3.a 1752 to 2236 498 to 15   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 484/484
(100 %)
1 diff
(99.8 %id)
AW594515 pooled germ cell tumors SPPL3.a 1752 to 2212 462 to 2       461/462
(99 %)
0 diff
(100 %id)
BE671804 pooled germ cell tumors SPPL3.a 1755 to 2212 459 to 2       458/459
(99 %)
0 diff
(100 %id)
CD366546 Alveolar Macrophage, lung SPPL3.a 1755 to 2389 653 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 635/635
(100 %)
3 diff
(99.6 %id)
DB526486 testis SPPL3.a 1757 to 2206 1 to 450     Submitted on the opposite strand 450/450
(100 %)
2 diff
(99.6 %id)
AI168495 breast SPPL3.a 1758 to 2212 460 to 6       455/460
(98 %)
0 diff
(100 %id)
DB539096 hippocampus SPPL3.a 1759 to 2193 1 to 437     Submitted on the opposite strand 437/439
(99 %)
11 diff
(97.5 %id)
DB515520 testis SPPL3.a 1765 to 2197 1 to 427     Submitted on the opposite strand 427/427
(100 %)
19 diff
(95.6 %id)
DB532016 hippocampus SPPL3.a 1765 to 2193 1 to 428     Submitted on the opposite strand 428/430
(99 %)
4 diff
(99.1 %id)
AI219983 pooled SPPL3.a 1775 to 2203 432 to 4       429/432
(99 %)
0 diff
(100 %id)
AW085214 pooled SPPL3.a 1779 to 2237 461 to 3       459/466
(98 %)
0 diff
(100 %id)
BI057423 placenta_normal SPPL3.a 1781 to 2204 1 to 422       422/431
(97 %)
11 diff
(97.5 %id)
BE379053 endometrium, adenocarcinoma cell line, uterus SPPL3.a 1781 to 2437 1 to 661       661/1087
(60 %)
15 diff
(98.7 %id)
AU185480 skin SPPL3.a 1784 to 2178 395 to 1       395/395
(100 %)
1 diff
(99.8 %id)
BQ360054 head_normal SPPL3.a 1785 to 2263 522 to 44       479/522
(91 %)
0 diff
(100 %id)
DN914174   SPPL3.a 1793 to 2239 1 to 447       447/447
(100 %)
0 diff
(100 %id)
AA970653 Kidney, kidney tumor SPPL3.a 1796 to 2202 407 to 1       407/407
(100 %)
6 diff
(98.6 %id)
AA988373 Kidney, kidney tumor SPPL3.a 1796 to 2212 420 to 4       417/420
(99 %)
0 diff
(100 %id)
AI679580 poorly differentiated adenocarcinoma withsignet ring cell features, stomach SPPL3.a 1797 to 2184 388 to 1       388/388
(100 %)
2 diff
(99.5 %id)
AI680017 poorly differentiated adenocarcinoma withsignet ring cell features, stomach SPPL3.a 1802 to 2184 383 to 1       383/385
(99 %)
1 diff
(99.8 %id)
AW242291 Kidney SPPL3.a 1802 to 2206 420 to 15   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 406/407
(99 %)
10 diff
(97.6 %id)
CF528743 placenta SPPL3.a 1802 to 2202 418 to 18   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 401/401
(100 %)
1 diff
(99.8 %id)
AA594662 colon, colon tumor RER+ SPPL3.a 1807 to 2203 397 to 1       397/397
(100 %)
4 diff
(99.0 %id)
R77834 placenta SPPL3.a 1812 to 2303 10 to 502       493/504
(97 %)
18 diff
(96.5 %id)
AI269095 Kidney SPPL3.a 1818 to 2202 385 to 1       385/385
(100 %)
1 diff
(99.8 %id)
AA576605 colon, colon tumor RER+ SPPL3.a 1822 to 2240 424 to 6       419/424
(98 %)
0 diff
(100 %id)
BE046448 colon, juvenile granulosa tumor SPPL3.a 1826 to 2393 568 to 2       567/572
(99 %)
0 diff
(100 %id)
W87297 liver and spleen SPPL3.a 1830 to 2195 370 to 1   fully sequenced,   370/370
(100 %)
2 diff
(99.5 %id)
AJ706483 bone marrow SPPL3.a 1831 to 2190 1 to 358       358/358
(100 %)
3 diff
(99.2 %id)
H06507 whole brain SPPL3.a 1837 to 2193 374 to 14   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 361/366
(98 %)
6 diff
(98.4 %id)
AA889625   SPPL3.a 1838 to 2199 365 to 4       362/365
(99 %)
0 diff
(100 %id)
H23755 brain SPPL3.a 1844 to 2301 1 to 466       466/466
(100 %)
9 diff
(98.1 %id)
BM681163 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid SPPL3.a 1853 to 2209 375 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 357/357
(100 %)
0 diff
(100 %id)
H48275 liver and spleen SPPL3.a 1861 to 2208 360 to 1       360/398
(90 %)
14 diff
(96.5 %id)
AA470783 colon SPPL3.a 1864 to 2209 347 to 1       347/347
(100 %)
3 diff
(99.2 %id)
C14942   SPPL3.a 1867 to 2078 1 to 214       214/214
(100 %)
4 diff
(98.2 %id)
N25981 melanocyte SPPL3.a 1871 to 2209 358 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 340/343
(99 %)
5 diff
(98.6 %id)
AA426463   SPPL3.a 1877 to 2195 342 to 24   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 319/319
(100 %)
2 diff
(99.4 %id)
BM151218 leukopheresis SPPL3.a 1885 to 2254 380 to 8       373/380
(98 %)
0 diff
(100 %id)
N63835 liver and spleen SPPL3.a 1890 to 2195 308 to 1   fully sequenced,   308/308
(100 %)
1 diff
(99.7 %id)
BF439848 brain, glioblastoma (pooled) SPPL3.a 1896 to 2387 493 to 2       492/493
(99 %)
0 diff
(100 %id)
AI580919   SPPL3.a 1900 to 2387 499 to 12   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 488/488
(100 %)
2 diff
(99.6 %id)
AA887867 colon, colon tumor RER+ SPPL3.a 1903 to 2201 299 to 1       299/299
(100 %)
1 diff
(99.7 %id)
AA376032 lung SPPL3.a 1911 to 2089 1 to 179       179/179
(100 %)
1 diff
(99.5 %id)
AA225014   SPPL3.a 1914 to 2365 1 to 452       452/452
(100 %)
5 diff
(98.9 %id)
AI208801   SPPL3.a 1915 to 2203 291 to 3       289/291
(99 %)
0 diff
(100 %id)
R43748 whole brain SPPL3.a 1921 to 2193 289 to 13   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 277/503
(55 %)
5 diff
(99.1 %id)
AA609145   SPPL3.a 1922 to 2218 302 to 6       297/302
(98 %)
0 diff
(100 %id)
DB511659 testis SPPL3.a 1934 to 2207 1 to 273     Submitted on the opposite strand 273/276
(98 %)
11 diff
(96.1 %id)
BF526617 brain, glioblastoma with EGFR amplification SPPL3.a 1939 to 2746 1 to 785       785/951
(82 %)
35 diff
(96.4 %id)
AA988831 carcinoid, lung SPPL3.a 1966 to 2198 233 to 1       233/233
(100 %)
2 diff
(99.2 %id)
T03502   SPPL3.a 1969 to 2241 274 to 1       274/274
(100 %)
7 diff
(97.5 %id)
AA927831 pooled SPPL3.a 1970 to 2203 237 to 4       234/237
(98 %)
0 diff
(100 %id)
AI334991 2 pooled tumors (clear cell type), Kidney SPPL3.a 1970 to 2393 430 to 7       424/430
(98 %)
0 diff
(100 %id)
BG055466 carcinoid, lung SPPL3.a 1974 to 2214 241 to 1       241/241
(100 %)
1 diff
(99.6 %id)
BP425528 small intestine SPPL3.a 1977 to 2390 1 to 414     Submitted on the opposite strand 414/414
(100 %)
2 diff
(99.6 %id)
AA628293   SPPL3.a 1981 to 2389 409 to 1       409/409
(100 %)
1 diff
(99.8 %id)
AA224953   SPPL3.a 1982 to 2378 417 to 21   AAA   397/408
(97 %)
0 diff
(100 %id)
DB538136 hippocampus SPPL3.a 2005 to 2193 1 to 191     Submitted on the opposite strand 191/192
(99 %)
4 diff
(98.0 %id)
N24392 melanocyte SPPL3.a 2013 to 2484 1 to 472   fully sequenced,   472/472
(100 %)
2 diff
(99.6 %id)
CB134804 Liver SPPL3.a 2033 to 2560 1 to 524       524/524
(100 %)
3 diff
(99.5 %id)
BU537032 mixed (pool of 40 RNAs) SPPL3.a 2054 to 2386 1 to 333       333/378
(88 %)
3 diff
(99.3 %id)
CA427939 Bone, Subchondral Bone SPPL3.a 2072 to 2854 783 to 1       783/783
(100 %)
7 diff
(99.2 %id)
BU633123 cell lines, Chondrosarcoma SPPL3.a 2092 to 2765 692 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 674/674
(100 %)
1 diff
(99.9 %id)
BF247470 hypernephroma, Kidney SPPL3.a 2103 to 2494 1 to 411       411/703
(58 %)
13 diff
(98.2 %id)
BG260370 bladder, transitional cell papilloma, cell line SPPL3.a 2104 to 2852 1 to 739   AAA   739/755
(97 %)
17 diff
(97.8 %id)
BE694187 breast SPPL3.a 2111 to 2288 195 to 18       178/195
(91 %)
0 diff
(100 %id)
BE694204 breast SPPL3.a 2111 to 2302 16 to 207       192/207
(92 %)
11 diff
(94.7 %id)
BG288775 bladder, transitional cell papilloma, cell line SPPL3.a 2126 to 2849 12 to 731       720/856
(84 %)
18 diff
(97.9 %id)
AW795836 uterus SPPL3.a 2129 to 2383 1 to 255       255/255
(100 %)
3 diff
(98.9 %id)
R75935 breast SPPL3.a 2156 to 2466 1 to 318       318/320
(99 %)
11 diff
(96.6 %id)
AW000936 Kidney SPPL3.a 2157 to 2657 1 to 501     Submitted on the opposite strand 501/501
(100 %)
8 diff
(98.5 %id)
BI050873 placenta_normal SPPL3.a 2161 to 2391 18 to 244       227/260
(87 %)
7 diff
(97.4 %id)
BI050874 placenta_normal SPPL3.a 2164 to 2390 19 to 242       224/242
(92 %)
6 diff
(97.6 %id)
BG171109 hypernephroma, cell line, Kidney SPPL3.a 2179 to 2879 1 to 691       691/756
(91 %)
27 diff
(96.5 %id)
BM987558 mixed SPPL3.a 2183 to 2386 222 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 204/212
(96 %)
0 diff
(100 %id)
AA639019 Ewing's sarcoma SPPL3.a 2187 to 2391 205 to 1       205/207
(99 %)
6 diff
(97.2 %id)
CA307670 Alveolar Macrophage, lung SPPL3.a 2190 to 2868 695 to 17   AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 679/679
(100 %)
1 diff
(99.9 %id)
BX442709 brain, fetal brain SPPL3.a 2192 to 2823 628 to 1       628/629
(99 %)
21 diff
(96.7 %id)
H80504 liver and spleen SPPL3.a 2261 to 2572 1 to 327   fully sequenced,   327/327
(100 %)
5 diff
(98.5 %id)
BM690757 eye, Retina Foveal and Macular SPPL3.a 2263 to 2837 8 to 580   AAA   573/586
(97 %)
6 diff
(99.0 %id)
BF115962 fibrotheoma, ovary SPPL3.a 2283 to 2843 562 to 1       562/562
(100 %)
2 diff
(99.7 %id)
AI928466 Kidney SPPL3.a 2288 to 2855 569 to 1       569/569
(100 %)
11 diff
(98.1 %id)
R70657 placenta SPPL3.a 2311 to 2754 1 to 447       447/447
(100 %)
2 diff
(99.6 %id)
N99359 liver and spleen SPPL3.a 2311 to 2692 1 to 384   fully sequenced, Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 384/384
(100 %)
3 diff
(99.3 %id)
BM694299 eye, RPE and Choroid SPPL3.a 2316 to 2611 1 to 296       296/296
(100 %)
0 diff
(100 %id)
W39077 parathyroid gland, parathyroid tumor SPPL3.a 2334 to 2704 1 to 377   fully sequenced,   377/377
(100 %)
6 diff
(98.5 %id)
AA420527   SPPL3.a 2334 to 2758 8 to 432       425/432
(98 %)
6 diff
(98.7 %id)
BP396359 pancreatic islet SPPL3.a 2357 to 2834 1 to 478     Submitted on the opposite strand 478/478
(100 %)
0 diff
(100 %id)
DB367628   SPPL3.a 2360 to 2839 479 to 1       479/510
(93 %)
10 diff
(98.1 %id)
AA868707   SPPL3.a 2366 to 2870 507 to 2       506/507
(99 %)
0 diff
(100 %id)
AI703274 carcinoid, lung SPPL3.a 2377 to 2863 503 to 15   AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 489/489
(100 %)
6 diff
(98.8 %id)
BX455665 brain, fetal brain SPPL3.a 2383 to 2859 483 to 2       482/567
(85 %)
0 diff
(100 %id)
AA888872   SPPL3.a 2385 to 2870 488 to 2       487/488
(99 %)
0 diff
(100 %id)
AW207718   SPPL3.a 2393 to 2866 482 to 15   AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 468/468
(100 %)
6 diff
(98.8 %id)
AI806255 pooled SPPL3.a 2397 to 2861 474 to 10       465/474
(98 %)
0 diff
(100 %id)
N49143 multiple sclerosis lesions SPPL3.a 2402 to 2507 1 to 106     Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 106/109
(97 %)
1 diff
(99.1 %id)
AA602349 adrenal adenoma, adrenal gland SPPL3.a 2415 to 2865 455 to 5       451/455
(99 %)
0 diff
(100 %id)
AI660755 thymus, pooled SPPL3.a 2417 to 2842 424 to 1       424/424
(100 %)
1 diff
(99.8 %id)
AA573514 colon SPPL3.a 2418 to 2766 370 to 22   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 349/349
(100 %)
2 diff
(99.5 %id)
FN088441 breast carcinoma SPPL3.a 2424 to 2504 1 to 83       83/83
(100 %)
6 diff
(92.8 %id)
BE328493 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney SPPL3.a 2427 to 2842 430 to 15   AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 416/416
(100 %)
0 diff
(100 %id)
DB530763 hippocampus SPPL3.a 2428 to 2866 1 to 438     Submitted on the opposite strand 438/438
(100 %)
12 diff
(97.3 %id)
BF884528 lung_tumor SPPL3.a 2438 to 2742 307 to 5     Submitted on the opposite strand 303/307
(98 %)
0 diff
(100 %id)
AW510978 pooled SPPL3.a 2438 to 2867 433 to 3       431/433
(99 %)
0 diff
(100 %id)
H97664 melanocyte SPPL3.a 2447 to 2868 424 to 1       424/424
(100 %)
4 diff
(99.1 %id)
H99143 melanocyte SPPL3.a 2454 to 2844 390 to 1   fully sequenced,   390/390
(100 %)
3 diff
(99.3 %id)
AA844022 parathyroid gland, parathyroid tumor SPPL3.a 2462 to 2844 382 to 1       382/382
(100 %)
1 diff
(99.8 %id)
BF884388 lung_tumor SPPL3.a 2470 to 2822 353 to 1     Submitted on the opposite strand 353/353
(100 %)
7 diff
(98.1 %id)
BE841315 stomach_normal SPPL3.a 2482 to 2680 198 to 3       196/198
(98 %)
0 diff
(100 %id)
R51298 whole brain SPPL3.a 2490 to 2863 385 to 12   AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 374/374
(100 %)
5 diff
(98.7 %id)
AA704248 liver and spleen SPPL3.a 2495 to 2745 251 to 1       251/251
(100 %)
2 diff
(99.3 %id)
FN090897 breast carcinoma SPPL3.a 2523 to 2616 96 to 3     Submitted on the opposite strand 94/96
(97 %)
0 diff
(100 %id)
AI886136 poorly differentiated adenocarcinoma withsignet ring cell features, stomach SPPL3.a 2531 to 2842 312 to 1       312/312
(100 %)
3 diff
(99.1 %id)
BU943053 mixed (pool of 40 RNAs) SPPL3.a 2538 to 2764 1 to 227       227/263
(86 %)
2 diff
(99.3 %id)
CV573185 cornea, eye SPPL3.a 2539 to 3160 1 to 625       625/625
(100 %)
6 diff
(99.1 %id)
H81420 liver and spleen SPPL3.a 2542 to 2841 307 to 1   fully sequenced,   307/307
(100 %)
7 diff
(97.8 %id)
FN113243 breast carcinoma SPPL3.a 2562 to 2628 67 to 1     Submitted on the opposite strand 67/67
(100 %)
0 diff
(100 %id)
N48366 multiple sclerosis lesions SPPL3.a 2565 to 2842 295 to 19   AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 277/277
(100 %)
6 diff
(97.9 %id)
BU735954 eye, fetal eyes SPPL3.a 2572 to 2861 316 to 28       289/316
(91 %)
0 diff
(100 %id)
C01112   SPPL3.a 2581 to 2813 1 to 231       231/260
(88 %)
2 diff
(99.3 %id)
AI475079 anaplastic oligodendroglioma, brain SPPL3.a 2623 to 2870 249 to 2       248/249
(99 %)
0 diff
(100 %id)
AI872772 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus SPPL3.a 2623 to 2838 217 to 1       217/217
(100 %)
1 diff
(99.6 %id)
AA938370 carcinoid, lung SPPL3.a 2641 to 2776 1 to 136     Submitted on the opposite strand 136/136
(100 %)
2 diff
(98.6 %id)
AA420594   SPPL3.a 2643 to 2839 218 to 24   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 195/195
(100 %)
2 diff
(99.0 %id)
AA350100 brain SPPL3.a 2664 to 2868 207 to 1       207/207
(100 %)
3 diff
(98.6 %id)
N71425 liver and spleen SPPL3.a 2668 to 2842 192 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 174/174
(100 %)
2 diff
(98.9 %id)
N89819 parathyroid gland, parathyroid tumor SPPL3.a 2674 to 2868 197 to 1   fully sequenced,   197/197
(100 %)
3 diff
(98.5 %id)
AW627454 2 pooled high-grade transitional celltumors, genitourinary tract SPPL3.a 2687 to 2842 154 to 1       154/154
(100 %)
1 diff
(99.4 %id)
BE300395 muscle, rhabdomyosarcoma SPPL3.a 2706 to 3425 48 to 788       741/789
(93 %)
61 diff
(92.3 %id)
AA169181   SPPL3.a 2708 to 2848 1 to 141     Submitted on the opposite strand 141/141
(100 %)
0 diff
(100 %id)
AA169309   SPPL3.a 2711 to 2843 133 to 1     Submitted on the opposite strand 133/133
(100 %)
0 diff
(100 %id)
BF204852 muscle, rhabdomyosarcoma SPPL3.a 2717 to 3374 1 to 664       664/743
(89 %)
27 diff
(96.4 %id)
EC452878 Prostate SPPL3.a 2725 to 2842 121 to 1       121/121
(100 %)
6 diff
(95.1 %id)
AW051264 serous papillary carcinoma, high grade, 2pooled tumors, uterus SPPL3.a 2750 to 2836 86 to 1       86/88
(97 %)
4 diff
(95.5 %id)
CB250609 Human Lung Epithelial cells, lung SPPL3.a 2770 to 3427 1 to 657     Submitted on the opposite strand 657/700
(93 %)
2 diff
(99.8 %id)
DN994147 brain, whole brain SPPL3.a 2817 to 3255 33 to 475       443/475
(93 %)
6 diff
(98.8 %id)
DN914175   SPPL3.a 2853 to 3427 577 to 3       575/577
(99 %)
0 diff
(100 %id)
AI338356   SPPL3.a 2887 to 3445 560 to 2       559/560
(99 %)
0 diff
(100 %id)
AL110147 uterus SPPL3.a 2896 to 4146 10 to 1259   tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 1250/1250
(100 %)
1 diff
(100.0 %id)
BQ327753 kidney_tumor SPPL3.a 2946 to 3151 8 to 220       213/225
(94 %)
17 diff
(92.5 %id)
AI092846 heart SPPL3.a 2964 to 3435 474 to 3       472/474
(99 %)
0 diff
(100 %id)
BI771773 pooled lung and spleen SPPL3.a 2968 to 3435 1 to 467   AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 467/467
(100 %)
1 diff
(99.8 %id)
TI_57182138   SPPL3.a 2968 to 3435 35 to 501   AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 467/501
(93 %)
6 diff
(98.9 %id)
BF876238 lung_tumor SPPL3.a 3024 to 3466 1 to 443       443/443
(100 %)
7 diff
(98.5 %id)
AW979207   SPPL3.a 3076 to 3627 111 to 662       552/662
(83 %)
6 diff
(99.1 %id)
AA848119 ovary SPPL3.a 3076 to 3241 8 to 172       165/172
(95 %)
6 diff
(96.6 %id)
AA627063 normal prostate, Prostate SPPL3.a 3084 to 3435 354 to 2       353/354
(99 %)
0 diff
(100 %id)
AI659631 Prostate SPPL3.a 3109 to 3435 327 to 1       327/327
(100 %)
0 diff
(100 %id)
AI675902 Prostate SPPL3.a 3109 to 3435 327 to 1       327/327
(100 %)
0 diff
(100 %id)
AI970824 Prostate SPPL3.a 3109 to 3435 327 to 1       327/327
(100 %)
2 diff
(99.4 %id)
BE859076 Prostate SPPL3.a 3109 to 3435 327 to 1       327/327
(100 %)
0 diff
(100 %id)
AL515379 neuroblastoma, placenta SPPL3.a 3120 to 4050 952 to 23   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 930/930
(100 %)
7 diff
(99.3 %id)
BF858098 prostate_tumor SPPL3.a 3143 to 3389 1 to 259       259/259
(100 %)
8 diff
(97.0 %id)
AA847797 germinal center B cell SPPL3.a 3144 to 3430 318 to 31       288/318
(90 %)
0 diff
(100 %id)
AW768486 lymph node, lymphoma, follicular mixed small and largecell SPPL3.a 3161 to 3429 293 to 25   AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 269/269
(100 %)
4 diff
(98.6 %id)
AI825127 pooled germ cell tumors SPPL3.a 3180 to 3430 251 to 1       251/251
(100 %)
1 diff
(99.7 %id)
AI825094 pooled germ cell tumors SPPL3.a 3187 to 3430 244 to 1       244/246
(99 %)
0 diff
(100 %id)
AI676074 Prostate SPPL3.a 3222 to 3443 238 to 17   AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 222/222
(100 %)
1 diff
(99.6 %id)
AI676081 Prostate SPPL3.a 3222 to 3443 238 to 17   AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 222/222
(100 %)
2 diff
(99.1 %id)
BG911834 anaplastic oligodendroglioma with 1p/19qloss, brain SPPL3.a 3233 to 4069 1 to 841       841/915
(91 %)
18 diff
(98.1 %id)
D45654 lung SPPL3.a 3294 to 3435 1 to 143     Submitted on the opposite strand 143/146
(97 %)
3 diff
(98.0 %id)
BG287467 bladder, transitional cell papilloma, cell line SPPL3.a 3471 to 4100 1 to 629       629/945
(66 %)
10 diff
(99.0 %id)
TI_154022076   SPPL3.a 3473 to 4152 763 to 84   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 680/686
(99 %)
1 diff
(99.9 %id)
CA438786 lung, Metastatic Chondrosarcoma SPPL3.a 3502 to 4152 669 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 651/651
(100 %)
1 diff
(99.9 %id)
BX508460   SPPL3.a 3603 to 4135 1 to 533       533/533
(100 %)
3 diff
(99.5 %id)
AF086117   SPPL3.a 3658 to 4152 1 to 495   tiling clone, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 495/495
(100 %)
0 diff
(100 %id)
N98320 lung SPPL3.a 3658 to 3939 1 to 283       283/286
(98 %)
4 diff
(98.7 %id)
N70143 lung SPPL3.a 3687 to 4152 464 to 1       464/465
(99 %)
8 diff
(98.3 %id)
CU443226 epidermis SPPL3.a 3707 to 4031 340 to 16     Submitted on the opposite strand 325/350
(92 %)
0 diff
(100 %id)
CU451450 epidermis SPPL3.a 3707 to 4035 340 to 13     Submitted on the opposite strand 328/358
(91 %)
0 diff
(100 %id)
CU451917 epidermis SPPL3.a 3707 to 4031 340 to 16     Submitted on the opposite strand 325/387
(83 %)
0 diff
(100 %id)
DB547302 hippocampus SPPL3.a 3733 to 4146 1 to 415     Submitted on the opposite strand 415/415
(100 %)
4 diff
(99.1 %id)
AL527159 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized SPPL3.b 1 to 845 1 to 845   tiling clone,   845/868
(97 %)
21 diff
(97.6 %id)
AL546675 placenta, Placenta Cot 25-normalized SPPL3.b 59 to 775 1 to 719   tiling clone,   719/719
(100 %)
7 diff
(99.1 %id)
AW238918 lung, cell line SPPL3.b 503 to 788 1 to 286     Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 286/286
(100 %)
4 diff
(98.7 %id)
R25551 whole brain SPPL3.b 594 to 958 1 to 368       368/414
(88 %)
6 diff
(98.6 %id)
R16671 liver and spleen SPPL3.b 650 to 973 1 to 326   tiling clone,   326/410
(79 %)
3 diff
(99.3 %id)
AL562834 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized SPPL3.b 1202 to 2108 907 to 1   tiling clone,   907/1015
(89 %)
14 diff
(98.7 %id)
AL571932 placenta, Placenta Cot 25-normalized SPPL3.b 1594 to 2295 711 to 3   tiling clone,   709/1018
(69 %)
0 diff
(100 %id)
R46707 whole brain SPPL3.b 1673 to 2139 484 to 7   tiling clone,   478/486
(98 %)
0 diff
(100 %id)
AW078769 lung, cell line SPPL3.b 1719 to 2137 427 to 11   tiling clone, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 417/417
(100 %)
8 diff
(98.1 %id)
R16672 liver and spleen SPPL3.b 1867 to 2150 286 to 1   tiling clone,   286/291
(98 %)
6 diff
(98.0 %id)
BG742241 skin SPPL3.c 1 to 798 1 to 798 exact tiling clone,   798/800
(99 %)
2 diff
(99.8 %id)
BQ329894 lung_normal SPPL3.c 32 to 328 13 to 318       306/318
(96 %)
6 diff
(98.2 %id)
BF170347 blood SPPL3.c 145 to 809 1 to 658       658/658
(100 %)
23 diff
(96.6 %id)
BX344090 Placenta Cot 25-normalized SPPL3.c 149 to 1188 1021 to 1   tiling clone,   1021/1021
(100 %)
49 diff
(95.3 %id)
BM721871 eye, fetal eye SPPL3.c 178 to 661 1 to 484       484/484
(100 %)
1 diff
(99.8 %id)
BC009551 Pancreas, epithelioid carcinoma SPPL3.c 183 to 1229 1 to 1047   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 1047/1047
(100 %)
2 diff
(99.9 %id)
BG252836 adenocarcinoma, cell line, Liver SPPL3.c 184 to 988 1 to 793       793/870
(91 %)
34 diff
(96.1 %id)
BE904435 epithelioid carcinoma, Pancreas SPPL3.c 201 to 795 1 to 617   available from MGC,   615/1065
(57 %)
48 diff
(95.5 %id)
AY358767   SPPL3.c 205 to 1072 1 to 867       867/872
(99 %)
3 diff
(99.7 %id)
BG913808 anaplastic oligodendroglioma with 1p/19qloss, brain SPPL3.c 213 to 950 1 to 741       741/820
(90 %)
22 diff
(97.4 %id)
BI334442 cervical carcinoma cell line, cervix SPPL3.c 246 to 935 1 to 691       691/691
(100 %)
1 diff
(99.9 %id)
BI254131 cervical carcinoma cell line, cervix SPPL3.c 263 to 1083 1 to 830       830/926
(89 %)
35 diff
(96.3 %id)
BM706060 eye, lens SPPL3.c 274 to 864 1 to 591       591/591
(100 %)
0 diff
(100 %id)
BQ130950 insulinoma, Pancreas SPPL3.c 289 to 796 8 to 515     Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 508/515
(98 %)
6 diff
(98.9 %id)
BU734619 eye, lens SPPL3.c 1075 to 1229 174 to 21   tiling clone,   154/185
(83 %)
0 diff
(100 %id)
DB311513 thalamus SPPL3.c 1375 to 1890 520 to 1   tiling clone,   520/522
(99 %)
5 diff
(99.1 %id)
BQ130682 insulinoma, Pancreas SPPL3.c 1379 to 1869 510 to 21   tiling clone, AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 490/490
(100 %)
1 diff
(99.8 %id)
BX640849 small intestine SPPL3.d 1 to 2302 564 to 2864 exact tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 2306/2864
(80 %)
9 diff
(99.7 %id)
BF848127 lung_normal SPPL3.d 775 to 1029 260 to 6     Submitted on the opposite strand 255/260
(98 %)
0 diff
(100 %id)
CB149089 Liver SPPL3.d 1007 to 1513 1 to 507       507/507
(100 %)
4 diff
(99.3 %id)
DA909456   SPPL3.e 1 to 555 2 to 556   tiling clone, capped   555/555
(100 %)
0 diff
(100 %id)
BE876855 large cell carcinoma, undifferentiated, lung SPPL3.e 72 to 762 1 to 686   tiling clone,   686/686
(100 %)
9 diff
(98.7 %id)
AW806275 uterus SPPL3.f 1 to 151 149 to 1   tiling clone,   149/160
(93 %)
7 diff
(95.7 %id)
AW176522 colon SPPL3.f 89 to 340 1 to 251   tiling clone,   251/253
(99 %)
5 diff
(98.1 %id)
DA446895 tongue, tumor tissue SPPL3.f 309 to 836 2 to 547 A109C L110T A111G M112H L114P ... tiling clone, capped   546/546
(100 %)
8 diff
(98.6 %id)
AW995674 breast_normal SPPL3.g 1 to 418 1 to 421   tiling clone,   421/421
(100 %)
20 diff
(95.3 %id)
AL701241 human skeletal muscle SPPL3.g 304 to 1014 1 to 715 exact tiling clone,   715/715
(100 %)
5 diff
(99.4 %id)
EB360720 eye, lens SPPL3.g 492 to 1171 680 to 1 V49A tiling clone,   680/680
(100 %)
6 diff
(99.2 %id)
DB236569 trachea SPPL3.h-u 1 to 579 2 to 583   tiling clone, capped   582/582
(100 %)
4 diff
(99.4 %id)
BF918816 nervous_tumor SPPL3.h-u 63 to 402 15 to 352       338/352
(96 %)
6 diff
(98.3 %id)
CV384258 nervous_tumor SPPL3.h-u 67 to 397 69 to 398       330/398
(82 %)
6 diff
(98.5 %id)
DB110858 thymus SPPL3.h-u 339 to 925 2 to 588   tiling clone, capped   587/587
(100 %)
1 diff
(99.9 %id)
BF918829 nervous_tumor SPPL3.h-u 343 to 663 359 to 36     Submitted on the opposite strand 324/370
(87 %)
0 diff
(100 %id)
BF800322 colon_ins SPPL3.h-u 518 to 829 315 to 5     Submitted on the opposite strand 311/351
(88 %)
0 diff
(100 %id)
AK097149 Spleen SPPL3.h-u 618 to 2556 1 to 1939 exact tiling clone, available from FLJ,   1939/1939
(100 %)
3 diff
(99.9 %id)
DA939327 Spleen SPPL3.h-u 619 to 1216 2 to 599 exact capped   598/598
(100 %)
1 diff
(99.9 %id)
DA928456 small intestine SPPL3.h-u 1706 to 2271 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
BF914790 uterus_tumor SPPL3.h-u 1979 to 2240 262 to 1     Submitted on the opposite strand 262/262
(100 %)
0 diff
(100 %id)
DB333063 Spleen SPPL3.h-u 1995 to 2556 562 to 1       562/562
(100 %)
1 diff
(99.9 %id)
BG339618 leiomyosarcoma cell line, uterus SPPL3.h-u 2137 to 2556 1 to 416   available from MGC, AAA   416/416
(100 %)
6 diff
(98.6 %id)
BC011943 Uterus, leiomyosarcoma SPPL3.h-u 2138 to 2556 1 to 419   tiling clone, available from MGC, AAA   419/419
(100 %)
1 diff
(99.8 %id)
AA312558   SPPL3.h-u 2582 to 3009 1 to 427   tiling clone,   427/427
(100 %)
4 diff
(99.1 %id)
CA942161 Pancreas, Purified pancreatic islet SPPL3.h-u 2999 to 3558 1 to 560   tiling clone,   560/560
(100 %)
0 diff
(100 %id)
BX476375   SPPL3.h-u 3257 to 3549 1 to 293       293/293
(100 %)
0 diff
(100 %id)
CD675135 eye, lens SPPL3.h-u 3257 to 3900 1 to 644   tiling clone, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 644/644
(100 %)
0 diff
(100 %id)
DA186718 amygdala SPPL3.h-u 3314 to 3877 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DB332217 small intestine SPPL3.h-u 3373 to 3900 529 to 1       529/529
(100 %)
3 diff
(99.5 %id)
CA941877 Pancreas, Purified pancreatic islet SPPL3.h-u 3688 to 4243 556 to 1   tiling clone,   556/556
(100 %)
1 diff
(99.9 %id)
BQ949768 sciatic nerve SPPL3.i-u 1 to 941 1 to 962 H36R I43M tiling clone,   962/970
(99 %)
36 diff
(96.3 %id)
DA131880 alzheimer cortex SPPL3.j 1 to 541 2 to 544 exact tiling clone, capped   543/543
(100 %)
2 diff
(99.7 %id)
BX646475   SPPL3.k-u 1 to 536 540 to 5 F5V G12A A20X tiling clone, Submitted on the opposite strand 536/540
(99 %)
0 diff
(100 %id)
AV755186 pituitary tumor SPPL3.k-u 52 to 233 1 to 179   tiling clone,   179/183
(97 %)
4 diff
(97.9 %id)
CV350224 stomach_normal SPPL3.l-u 1 to 407 1 to 411 F5L E17* tiling clone,   411/429
(95 %)
29 diff
(93.3 %id)
AW887614 ovary SPPL3.m-u 1 to 348 16 to 364 exact tiling clone,   349/365
(95 %)
5 diff
(98.7 %id)
CB305791 lung, Primary Lung Cystic Fibrosis EpithelialCells Gene SPPL3, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BF358985 lung_tumor Gene SPPL3, variant not shown              
AV691174 hepatocellular carcinoma Gene SPPL3, variant not shown         Suspected internal deletion, this clone was ignored    
AL549686 placenta, Placenta Cot 25-normalized Gene SPPL3, variant not shown         Suspected internal deletion, this clone was ignored    
BX344091 Placenta Cot 25-normalized Gene SPPL3, variant not shown              
AA378783 synovial membrane Gene SPPL3, variant not shown              
AA356016   Gene SPPL3, variant not shown              
BP352918   Gene SPPL3, variant not shown              
DA741475   Gene SPPL3, variant not shown       capped      
BJ992444 hepatoblastoma Gene SPPL3, variant not shown         This clone was ignored    
BJ992445 hepatoblastoma Gene SPPL3, variant not shown         This clone was ignored    
CN406294 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells Gene SPPL3, variant not shown              
BX421660 T cells (Jurkat cell line) Gene SPPL3, variant not shown         This clone was ignored    
FN059027 breast carcinoma Gene SPPL3, variant not shown         Submitted on the opposite strand    
DB461074 testis Gene SPPL3, variant not shown              
DB470756 hippocampus Gene SPPL3, variant not shown              
BF370548 prostate_normal Gene SPPL3, variant not shown              
AW947442 lung_tumor Gene SPPL3, variant not shown         Submitted on the opposite strand    
TI_927047746   Gene SPPL3, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
TI_927047755   Gene SPPL3, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
DB309376 hippocampus Gene SPPL3, variant not shown         This clone was ignored    
DA325928 hippocampus Gene SPPL3, variant not shown       capped This clone was ignored    
CR612222 Placenta Cot 25-normalized Gene SPPL3, variant not shown         Suspected internal deletion, this clone was ignored    
DA511068 brain Gene SPPL3, variant not shown       capped      
AA398028   Gene SPPL3, variant not shown              
BE296638 muscle, rhabdomyosarcoma Gene SPPL3, variant not shown              
BE296633 muscle, rhabdomyosarcoma Gene SPPL3, variant not shown         Suspected internal deletion, this clone was ignored    
BF966194 brain, hippocampus Gene SPPL3, variant not shown         This clone was ignored    
BF966853 brain, hippocampus Gene SPPL3, variant not shown         This clone was ignored    
BG260754 bladder, transitional cell papilloma, cell line Gene SPPL3, variant not shown         Suspected internal deletion, this clone was ignored    
BG391886 embryonal carcinoma, cell line, testis Gene SPPL3, variant not shown              
BQ218639 epithelioid carcinoma, Pancreas Gene SPPL3, variant not shown              
TI_149313977   Gene SPPL3, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h-u, .i-u, .j, .k-u, .l-u, .m-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DC